InMode Ltd vs Philip Morris International Inc. — how do they compare? InMode Ltd trades at $15.15 (market cap $872.08M), while Philip Morris International Inc. trades at $186.36 (market cap $290.24B). The key difference: Philip Morris International Inc. is far larger — about 332.8× InMode Ltd's market cap, and Philip Morris International Inc. pays a 3.16% dividend while InMode Ltd pays none. Which is the better fit depends on your goals.
| INMD | PM | |
|---|---|---|
Market Cap | $872.08M | $290.24B |
Sector | Technology | Consumer Staples |
52-Week High | $16.62 | $200.17 |
52-Week Low | $12.76 | $144.33 |
Enterprise Value | $375.42M | $333.36B |
Dividend Yield | — | 3.16% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $186.00, down 1.88% on the day, with a neutral technical signal. The stock shows strong profitability with a 25.56% net income margin and has beaten earnings estimates in two of the last three quarters. Recent news highlights a $500 million impairment charge and a lowered profit forecast due to cost pressures, though the IQOS brand was recognized as a top global brand. Analyst consensus remains bullish with a $211.17 price target.
The outlook is mixed; strong cash flow and brand strength support long-term value, but near-term headwinds from cost inflation and illicit market growth pose risks. The current valuation at a P/E of 25.57 appears fair given earnings resilience, making PM a hold for investors tolerant of sector-specific volatility.
Trailing returns across standard periods
Latest headlines on both assets
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →